Sponsor:
Flamingo Therapeutics NV
Code:
NCT05814666
Conditions
HNSCC
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Danvatirsen
Pembrolizumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-22. This information was provided to ClinicalTrials.gov by Flamingo Therapeutics NV on 2024-12-31.